Latest / Behind the Bastards / Part One: The Vioxx Scandal: How Big Pharma Killed More Americans Than Vietnam
Transcript
- 0:01Speaker 1: Also media, Welcome back to Behind the Bastards, a podcast
- 0:09Speaker 1: where Sophie is not in the room right now. So
- 0:12Speaker 1: doctor cave Hoda and I are are the foxes watching
- 0:17Speaker 1: the hen house? That is also we're we're also the hens.
- 0:21Speaker 2: I am the producer, I am the captain.
- 0:24Speaker 1: Now we're like hin foxes, like like a cat dog situation.
- 0:28Speaker 1: Although I imagine a hen fox. The fox is just
- 0:30Speaker 1: going to try to eat it's hin. That's part of
- 0:32Speaker 1: its butt, I imagine.
- 0:34Speaker 2: I love your quaint country colloquialisms. It's great. I don't
- 0:38Speaker 2: know what they mean.
- 0:39Speaker 1: But oh yeah, you're probably too young for that cartoon.
- 0:42Speaker 1: I was the right age for it.
- 0:44Speaker 2: Now.
- 0:45Speaker 1: Yes, doctor Hoda miser care expert legally my doctor, Do
- 0:51Speaker 1: you have any do you have any theories that you
- 0:53Speaker 1: can't prove, that are unprovable, that are probably nonsense, that
- 0:56Speaker 1: you nonetheless believe about health? About health? Yeah, yeah, I
- 1:02Speaker 1: got a lot.
- 1:08Speaker 2: As a doctor. I feel like I should. Uh you know,
- 1:12Speaker 2: I will talk to you at great length about how
- 1:15Speaker 2: supplements are a fantastic waste of time. Uh And I
- 1:20Speaker 2: will tell you in detail, and I have on many
- 1:24Speaker 2: episodes why they're more dangerous generally than they are good
- 1:27Speaker 2: and you should only use them with strict instructions from
- 1:31Speaker 2: your physician. But that being said, I feel like ginger
- 1:38Speaker 2: really helps me in like a power up way that
- 1:41Speaker 2: it doesn't. I know it doesn't, but I love it,
- 1:44Speaker 2: and the placebo effect is so strong for me that,
- 1:48Speaker 2: you know, Yeah, Ginger's my magic thing, my little magic
- 1:54Speaker 2: creation in my mind that works more than it really does.
- 1:57Speaker 1: Yeah, I'm not big on supplements. I do take my
- 2:00Speaker 1: doctor advised me to take for blood pressure, calcium and potassium.
- 2:06Speaker 2: Uh so I do.
- 2:08Speaker 1: I do. I do some of that, which I've noticed
- 2:11Speaker 1: I don't get cramps as much as I used to,
- 2:13Speaker 1: So I guess I guess I'll call that a win.
- 2:17Speaker 1: I do love looking it into the different potential side effect.
- 2:20Speaker 1: I love going on to like biohacking subreddits and seeing
- 2:23Speaker 1: people talk about like the side effects they're having with
- 2:27Speaker 1: with various weird supplements they're taking to never die. Although
- 2:32Speaker 1: my favorite is the Lion's Main subreddit. So Lion's Main
- 2:35Speaker 1: is like a mushroom that does have like some it
- 2:37Speaker 1: does have like an effect on your your your brain right,
- 2:40Speaker 1: Like there's there's actually some like studied benefits of Lion's maine.
- 2:43Speaker 1: But it's like it's a pretty mild supplement, but there's
- 2:46Speaker 1: this group of people who are convinced that like taking
- 2:49Speaker 1: it once has like destroyed their life in the way
- 2:51Speaker 1: that like a huge dose of psilocybin. Mushrooms might have
- 2:55Speaker 1: like mind alter effects. And it's like, man, everyone at people,
- 2:58Speaker 1: I don't put like it in their smoothies.
- 2:59Speaker 2: I don't.
- 3:00Speaker 1: I don't think it's the fucking lions main that's giving
- 3:02Speaker 1: you nightmares for the last seven years of your life.
- 3:06Speaker 2: I mean that is that is That's the kind of
- 3:09Speaker 2: thing I hear a lot about, Like every medication you
- 3:12Speaker 2: name it out there, someone has had someone blames that
- 3:15Speaker 2: medication for their life being in shambles. Yeah, and you
- 3:19Speaker 2: know it's medication we're talking about today. Lots of risks,
- 3:23Speaker 2: It's true. They all they all do some more than others.
- 3:26Speaker 2: I think we're probably going to discuss here. But uh, yeah,
- 3:29Speaker 2: I don't know if Lion's maine, which I'm not familiar with,
- 3:31Speaker 2: really so it's us.
- 3:33Speaker 1: It's a mushroom, you know, it's got you know, some
- 3:35Speaker 1: mushrooms have like, uh neurological impacts and stuff on people.
- 3:40Speaker 1: But you know, my My particular favorite medical theory, doctor
- 3:43Speaker 1: doctor Hoda is that obviously cigarettes are bad, terrible for
- 3:49Speaker 1: for almost everyone, nearly always horrible. But I think there's
- 3:52Speaker 1: a slightly less than one percent of the population that
- 3:54Speaker 1: have a genetic abnormality that makes cigarettes make them live forever.
- 3:59Speaker 1: Because every now and then I'll meet you know, sometimes
- 4:02Speaker 1: in like little corners of the world or whatever. I've
- 4:05Speaker 1: met f like little old ladies in Japan or like
- 4:06Speaker 1: ninety six, and they're like, yeah, I've been chainsmoking cigarette
- 4:09Speaker 1: since I was like eleven years old or something like that,
- 4:12Speaker 1: and it's like, clearly it works for you. Like there's
- 4:14Speaker 1: some some minority of the population that cigarettes make and vulnerable.
- 4:19Speaker 2: I feel like this is that meme of the plane
- 4:21Speaker 2: that returns from war with the bullet holes. You're never
- 4:26Speaker 2: gonna hear me say cigarettes are okay. They know what
- 4:29Speaker 2: they've done, they know.
- 4:31Speaker 1: I know they've killed They've killed uncountable more people than
- 4:34Speaker 1: war in the twentieth century, and war killed so many
- 4:37Speaker 1: people in the twentieth century. But every now and then
- 4:41Speaker 1: I'll meet some like ninety year old woman who smokes
- 4:43Speaker 1: four packs a day and she's doing fine. So clearly
- 4:46Speaker 1: clearly science doesn't understand everything about the maligned cigarette.
- 4:51Speaker 2: Don't smoke cigarettes, okay enough.
- 4:53Speaker 1: Don't vape o vape that's the one that worries I mean, like,
- 4:57Speaker 1: especially since all of my friends vape heavily. It's one
- 4:59Speaker 1: of those like, yeah, but it's got to be doing
- 5:01Speaker 1: something right, Like it's got something.
- 5:04Speaker 2: Like oh, for sure, for sure, I'm a huge fan
- 5:07Speaker 2: of vaping. Either there is harm reduction. There's a good
- 5:10Speaker 2: argument about that, but I'm not You're not going to
- 5:12Speaker 2: see me promote vaping either.
- 5:14Speaker 1: That said, you know, when we get into the whole
- 5:18Speaker 1: what is it responsible to tell people to do or not?
- 5:21Speaker 1: A lot of times the greatest harms are things that
- 5:23Speaker 1: people like cigarettes, were told by their doctors are great
- 5:27Speaker 1: for them. And today we're going to tell one of
- 5:29Speaker 1: those stories, a story of a drug that became the
- 5:34Speaker 1: lead seller for a major pharmaceutical company that was backed
- 5:38Speaker 1: by an alliance of physicians who had shall we say,
- 5:41Speaker 1: some you know, financial interest in finding that this thing worked.
- 5:46Speaker 1: Today we're talking about vox, which is I think an
- 5:50Speaker 1: infamous name now in the annals of medical science. People
- 5:53Speaker 1: tend to know what I'm talking about. But if you
- 5:55Speaker 1: don't this killed more Americans than the Vietnam War. Like that,
- 6:00Speaker 1: that's the story we're getting into today. What do you
- 6:06Speaker 1: know about ViOS.
- 6:08Speaker 2: You know, I was too young to really be I
- 6:11Speaker 2: wasn't really practicing medicine when it happened, but I did
- 6:14Speaker 2: know about it, and I've heard some about it since then.
- 6:17Speaker 2: I'm really very fascinated by the story and I'm really
- 6:21Speaker 2: looking forward, yeah to getting into it today. So I'm
- 6:23Speaker 2: excited about that. I will say I think it was
- 6:27Speaker 2: It feels like a turning point in regards to how
- 6:30Speaker 2: people looked at pharmaceutical companies. I think it was really
- 6:33Speaker 2: like a sentinel event in that, Like I think doctors
- 6:37Speaker 2: were always skeptical of pharmaceutical companies. We still are, but
- 6:43Speaker 2: I think that was when people started to become cynical.
- 6:46Speaker 2: That change started. It's because of what happened with Viox
- 6:50Speaker 2: and VIAX.
- 6:51Speaker 1: I think it's also important, Like Vias, the scandal hits
- 6:55Speaker 1: kind of right as you know, before we're really starting
- 6:57Speaker 1: to realize what has gone down with the h with
- 7:02Speaker 1: the prescription painkiller epidemic, like when that's starting to really
- 7:06Speaker 1: take off and we start to realize how fucked up
- 7:08Speaker 1: some of what Purdue did. And so this one two punch,
- 7:12Speaker 1: it really is responsible. I think that's very salient what
- 7:15Speaker 1: you said. It's really responsible for a lot of I mean,
- 7:17Speaker 1: for like RFK is about to be the director of
- 7:19Speaker 1: Health and Human Services right, Like it has a lot
- 7:23Speaker 1: to do with that, because this is hard for people
- 7:25Speaker 1: to imagine, Like folks my age, I have always grown
- 7:28Speaker 1: up with big Pharma being like the devil, right in
- 7:31Speaker 1: part because like as soon as I turned eighteen nineteen,
- 7:33Speaker 1: I was hanging out with a lot of hippies, but
- 7:36Speaker 1: in part because like there were a lot of like
- 7:39Speaker 1: really really high body count pharmaceutical company scandals, and it
- 7:42Speaker 1: is hard for some people to remember that, like, pharmaceutical
- 7:45Speaker 1: companies used to be very popular and well regarded in
- 7:49Speaker 1: a lot of cases, in part because the generation, the
- 7:52Speaker 1: generation that was kind of running the world in the
- 7:54Speaker 1: eighties and nineties had largely lived through like and we're
- 7:58Speaker 1: still close to Oh, polio is this nightmare that just
- 8:01Speaker 1: sweeps through and devastates like a generation. You know, you
- 8:05Speaker 1: have these flues and then suddenly you have half as
- 8:07Speaker 1: many friends after the flu passes and that stops being
- 8:11Speaker 1: a thing. And they're really the first generation you know,
- 8:14Speaker 1: kind of the later boomers that didn't have to deal
- 8:17Speaker 1: with that, but we're close enough to it to like
- 8:18Speaker 1: really appreciate, like, Wow, medical science did us as solid.
- 8:23Speaker 2: Yeah, And we've drifted just far enough from that now
- 8:26Speaker 2: that people have forgotten and revising whole parts of history.
- 8:30Speaker 1: And I mean part of the problem is that shit
- 8:32Speaker 1: like the Vox scandal and like the produe pharmaceutical scandals
- 8:37Speaker 1: are closer to us than for example, fucking people being
- 8:41Speaker 1: an iron lungs or whatever.
- 8:43Speaker 3: You know.
- 8:44Speaker 1: Recency bias is a hell of a thing. But since
- 8:46Speaker 1: time immemorial, mankind has struggled against a terrible and implacable enemy, pain.
- 8:52Speaker 1: Luckily for us, mother nature has provided a perfect painkiller, opium,
- 8:56Speaker 1: that could be used as the basis for a variety
- 8:58Speaker 1: of excellent medicines that really do exactly what they say
- 9:02Speaker 1: they're going to do. Unfortunately, these medicines come with a downside,
- 9:06Speaker 1: which is that when you start taking them, you might
- 9:09Speaker 1: not ever want to stop taking them. For some people,
- 9:13Speaker 1: this destroys their life and take a sip of my
- 9:15Speaker 1: cratem tea. And since all the all the health cops
- 9:20Speaker 1: out there don't like people pill popping, like doctor House
- 9:23Speaker 1: even though he made it look incredibly sexy. Did he.
- 9:29Speaker 2: Hate that show?
- 9:30Speaker 1: Oh man, you're not not a house fan. Huh No,
- 9:33Speaker 1: it's just so ridiculous.
- 9:35Speaker 2: I mean, all of those shows, Scrubs is the only
- 9:38Speaker 2: one that's watchable for me.
- 9:40Speaker 1: Scrubs. Really yeah, I mean I did rewatch. I like
- 9:42Speaker 1: to imagine that the movie Platoon is like a like
- 9:46Speaker 1: the the what you might call it the prequel, the prequel.
- 9:50Speaker 2: Toy said it.
- 9:53Speaker 1: Yeah, that's why doctor Cox is the way he is.
- 9:57Speaker 1: He had to spend that night hiding under his friend's
- 9:58Speaker 1: bodies in a trench line. You had to watch Willem
- 10:04Speaker 1: Dafoe die. Spoilers for the movie Platoon, which is older
- 10:09Speaker 1: than most of you, might be illder than me. I
- 10:12Speaker 1: don't remember when Blagin came out anyway. So because of
- 10:16Speaker 1: you know, health cops don't like people becoming horrible pill
- 10:19Speaker 1: addicts and destroying their lives. There's a market, a massive
- 10:23Speaker 1: market for anyone who could create a thing that is
- 10:25Speaker 1: an effective painkiller that doesn't also inspire people to break
- 10:29Speaker 1: into cars for drug money. Right, there's a lot of
- 10:31Speaker 1: money and a painkiller that does not have the kind
- 10:34Speaker 1: of abuse potential that opiates have. A Ceda medaphin was
- 10:37Speaker 1: discovered back in the eighteen eighties, but it took us
- 10:40Speaker 1: intol the nineteen forties to actually figure out how to
- 10:42Speaker 1: use it as a drug. And for reasons that are
- 10:45Speaker 1: more complex than it's really worth getting into. Because of
- 10:48Speaker 1: how it was discovered, a ceda medaphin could never be
- 10:50Speaker 1: patented right, which means pharmaceutical companies are not super attracted
- 10:55Speaker 1: to a ceda medaphin right because like, well, you know,
- 10:58Speaker 1: you can't only sell it for so much of every
- 11:00Speaker 1: one can make the damn thing. This meant that pharmaceutical
- 11:02Speaker 1: companies had to get creative marketing it in order to
- 11:05Speaker 1: make it profitable. As a result, tailand All became a
- 11:08Speaker 1: foundational part of the marketing drugs story. McNeil, the company
- 11:12Speaker 1: that started selling acid of metaphine in the US, initially
- 11:16Speaker 1: framed it as a painkiller for children. And the way
- 11:19Speaker 1: the ad campaign that they use is very weird for
- 11:22Speaker 1: some reason, and I've never found out why, but for
- 11:24Speaker 1: unclear reasons, they had a huge number of toy fire
- 11:27Speaker 1: trucks and the way that they first sold Thailand all
- 11:31Speaker 1: was they like stuffed fire trucks to the brim with
- 11:33Speaker 1: pills of tailan All and like made that. That was
- 11:36Speaker 1: their marketing ploy to like get little parents to buy
- 11:39Speaker 1: tilant All for their small show.
- 11:41Speaker 2: Always love fire trucks. Kids love Thailand All too. They
- 11:44Speaker 2: love their Tilan Hall, they love their living damage, and
- 11:48Speaker 2: they love their fire trucks. This is a thing about kids.
- 11:51Speaker 1: This is why I'm going to try to make the
- 11:54Speaker 1: chief Christmas toy of this season the little Doctor House
- 11:58Speaker 1: pill popper set where because kids, you can take as
- 12:00Speaker 1: much tilt All as you want.
- 12:02Speaker 2: Right, you'll be like a big cane. That's dispenser, right,
- 12:09Speaker 2: and that's your little house toy for kids.
- 12:12Speaker 1: Takes your little house toy for kids. Yeah, now this
- 12:16Speaker 1: worked better than any it had any right to work.
- 12:18Speaker 1: Advertising was easier back then. I imagine today if you
- 12:21Speaker 1: tried to sell parents on a chat, which is like
- 12:24Speaker 1: a firetruck Philip Bills, I don't know this would make
- 12:28Speaker 1: me feel good about any of this, But you have
- 12:30Speaker 1: to remember so jaded.
- 12:31Speaker 2: Now that's a problem. We're jaded.
- 12:33Speaker 1: We're jaded, and like, prior to Thailand All, the chief
- 12:36Speaker 1: method of dealing with pain for small children was to
- 12:38Speaker 1: give them a spoonful of heroin and hope they woke
- 12:40Speaker 1: up the next day right like. They literally sold it
- 12:42Speaker 1: as a cough medicine for children. So the fire truck
- 12:47Speaker 1: plan worked well. It worked so well that McNeil gets
- 12:49Speaker 1: bought by Johnson and Johnson. And that's actually when it
- 12:52Speaker 1: gets the name thailand All. McNeil's not selling it under
- 12:54Speaker 1: tiland All Johnson and Johnson, which, for whatever reason is
- 12:57Speaker 1: a great name. I don't know why. Doesn't make much
- 13:01Speaker 1: sense to me. Easier remember, Yeah, So, in subsequent decades,
- 13:05Speaker 1: tailand All was found to be useful in numerous medical
- 13:07Speaker 1: applications as a painkiller, a fever reducer, and about a
- 13:10Speaker 1: million other things. It was joined in the mild painkiller
- 13:14Speaker 1: category by Bear's aspirin, which had its roots in herbal
- 13:17Speaker 1: medications that had been used by peoples around the world
- 13:20Speaker 1: since time immemorial. The Assyrians and Sumerians had actually been
- 13:24Speaker 1: using willow leaves as treatments for various ailments, and a
- 13:26Speaker 1: variety of plants containing sallasitic acid have been used in
- 13:29Speaker 1: similar ways all over the globe. So Aceta metaphine and
- 13:32Speaker 1: aspirin both quickly became foundational pieces of any medicine cabinet,
- 13:36Speaker 1: but they weren't perfect. One issue that both painkillers had
- 13:39Speaker 1: is that they could interact with other drugs or just
- 13:42Speaker 1: interact badly with certain patients to cause substantial stomach distress.
- 13:46Speaker 1: In the most severe cases, this could result in stomach
- 13:49Speaker 1: ulcers and sometimes life threatening stomach ulcers. So, you know,
- 13:53Speaker 1: this is one of these problems, is like you want
- 13:55Speaker 1: to be able to give people as much of this
- 13:57Speaker 1: as they need because it's you know, non adict diven
- 14:00Speaker 1: helps with a lot of things, but there's some hard
- 14:02Speaker 1: limits based on what this does to people's stomachs well
- 14:05Speaker 1: and livers.
- 14:06Speaker 2: I mean menafin, Yeah, you know, that's worldwide one of
- 14:11Speaker 2: the biggest causes of liver failure from people taking too
- 14:14Speaker 2: much a cedum, menaphin, and and then yeah, these other
- 14:17Speaker 2: nonstroidal anti inflammatory drugs. They're the kind of thing that
- 14:21Speaker 2: make me a gastro introologist have to go in the
- 14:24Speaker 2: middle of the night to go put a scope into
- 14:26Speaker 2: someone's stomach because they're bleeding a ton in the setting
- 14:30Speaker 2: of you know, somebody's who's swallowed too much advil or
- 14:35Speaker 2: something like a leave or something.
- 14:37Speaker 1: Yeah, and I think that probably doesn't didn't make it
- 14:39Speaker 1: as much into my research, just because in the seventies
- 14:41Speaker 1: they didn't have as much data on that made sure
- 14:43Speaker 1: they all they're all focused at least on the ulcers.
- 14:46Speaker 1: But yeah, like the there's a there's a great bluegrass
- 14:49Speaker 1: song called codeine with the lyrics Codeine, Codeine, You're the
- 14:52Speaker 1: nicest thing I've seen for a while. And if you
- 14:54Speaker 1: know anything about codine, it's the worst of the painkillers
- 14:57Speaker 1: to get high on, which makes the song better because
- 15:00Speaker 1: if you are the kind of person for whom like
- 15:01Speaker 1: codeine is the nicest thing you've ever encountered, your life
- 15:05Speaker 1: has been a hard life.
- 15:06Speaker 2: Yes, you have had a bad light.
- 15:13Speaker 1: So by the late twentieth century, pharmaceutical researchers had started
- 15:17Speaker 1: poking around both compounds to try to find ways to
- 15:20Speaker 1: create new variants that didn't have any of those downsides.
- 15:23Speaker 1: They called these hypothetical medications super aspirins, because research pharmacologists
- 15:28Speaker 1: aren't great at naming things terrible, terrible, terrible. The quest
- 15:33Speaker 1: for a super aspirin seems to have really started in
- 15:35Speaker 1: nineteen seventy one when a gaggle of British researchers, I
- 15:38Speaker 1: think that's how you term a group of researchers tried
- 15:42Speaker 1: to unravel the mystery of why aspirin and thailand all work. Again,
- 15:45Speaker 1: we knew these things were good painkillers, and we knew
- 15:48Speaker 1: they did other stuff. The method of action was unclear
- 15:51Speaker 1: to us at this point, which is a startling amount
- 15:53Speaker 1: of the time. True with drugs. There's a lot of
- 15:55Speaker 1: medications you might be on that the doctors don't precisely
- 15:59Speaker 1: know why it does what it does. We have somebody,
- 16:02Speaker 1: but like a.
- 16:02Speaker 2: Lot of this is still being you want to know. Yeah,
- 16:06Speaker 2: with a lot of things we do in medicine that
- 16:08Speaker 2: we yeah, were we just they seem to work, it doesn't.
- 16:12Speaker 1: It definitely helps. We're not sure why. But in this case,
- 16:16Speaker 1: the research research board fruit. As author Tom NeSSI describes
- 16:19Speaker 1: in his excellent book Poison Pills quote, when an injury
- 16:23Speaker 1: takes place in the body, chemicals known as prostaglandins rush
- 16:26Speaker 1: into the wound site to deal with the swelling, heat,
- 16:28Speaker 1: and pain. Prostaglandins have important functions for human well being.
- 16:32Speaker 1: They play a part in ovulation, to protect the stomach
- 16:34Speaker 1: from acids and to ensure that blood clots normally. The
- 16:37Speaker 1: latter effect explains why asprom reduces heart disease. It prevents
- 16:40Speaker 1: clumps of blood from forming that can potentially block an artery.
- 16:43Speaker 1: Prostaglandins actually make nerve endings more sensitive to pain. N
- 16:47Speaker 1: s A I, d's in, SAIS and insetes.
- 16:52Speaker 2: Yeah.
- 16:53Speaker 1: Insades reduce the production of prostaglandin and thereby relieve the
- 16:56Speaker 1: pain associated with swelling and soreness. Unfortunately, in the process
- 16:59Speaker 1: of doing so, they irritate the stomach. Sometime after this discovery,
- 17:03Speaker 1: scientists found that a substance called cyclooxygenase or COX, was
- 17:09Speaker 1: produced as part of the mobilization of prostaglandin and was
- 17:12Speaker 1: the enzyme that actually controlled pain and inflammation.
- 17:15Speaker 2: You're doing a fantastic job, by the way, a moment,
- 17:18Speaker 2: you're doing a really good You didn't call it Cox,
- 17:20Speaker 2: by the way, Cox.
- 17:21Speaker 1: Yeah, I was going to because doctor Cox.
- 17:24Speaker 2: Yeah, yeah, in his honor. But this is interesting. I
- 17:27Speaker 2: didn't expect I was going to be getting this like
- 17:30Speaker 2: trip down medical school, like memory lane. This is fantastic.
- 17:34Speaker 2: You're doing great.
- 17:35Speaker 1: We try to be complete. Also, doctor Cox isn't born
- 17:37Speaker 1: on the fourth of July, which you can consider a
- 17:39Speaker 1: stealth sequel to Platoon if you assume that Williem Dafoe
- 17:42Speaker 1: actually survived his injuries in Platoon?
- 17:45Speaker 2: Was he in.
- 17:48Speaker 1: He's the crazy vet in Mexico that fucking Tom Cruise
- 17:51Speaker 1: meets when they're both like doing drugs and hanging out
- 17:53Speaker 1: with prostitutes after losing their legs. Yeah, it's great, oh Man,
- 17:57Speaker 1: that movie rules. So these researchers began to theorize that
- 18:02Speaker 1: COX might include an additional substance that was separately the
- 18:05Speaker 1: cause for stomach irritation. If someone could find an isolate
- 18:09Speaker 1: said substance, it might allow for the creation of a
- 18:11Speaker 1: super aspirin. But no one even knew if this theoretical
- 18:14Speaker 1: substance was real, and pharmaceutical companies didn't exactly feel an
- 18:18Speaker 1: immediate urge to jump on the matter because they had
- 18:20Speaker 1: no idea if this was even a thing. Fast forward
- 18:23Speaker 1: to nineteen ninety A pharmacologist named Needleman gets close to
- 18:27Speaker 1: isolating the COX enzyme that he believes is causing all
- 18:30Speaker 1: of the problems he hasn't actually doesn't actually find it,
- 18:33Speaker 1: but he's confident enough in its existence for reasons that
- 18:36Speaker 1: I'm sure makes sense to biochemists that he gives it
- 18:39Speaker 1: a name Cox.
- 18:41Speaker 2: Two.
- 18:41Speaker 1: Research goes on, and in July of nineteen ninety two,
- 18:44Speaker 1: several teams of researchers in Montreal announced that they have
- 18:47Speaker 1: isolated two enzymes COX two and one, of which COX
- 18:51Speaker 1: two seems to be the causal agent behind the side
- 18:54Speaker 1: effects in SAIDs provoke in some patients. Right, So nineteen
- 18:58Speaker 1: ninety two they found finally this thing they've been looking
- 19:02Speaker 1: for for like twenty years. Right, this is the reason
- 19:05Speaker 1: they believe why your aspirin or whatever can cause stomach olcers.
- 19:10Speaker 1: So the researchers used that if you can find a
- 19:12Speaker 1: medication that blocks COS two and you compound it with
- 19:16Speaker 1: like a painkiller with a seat of metaphine or whatever,
- 19:18Speaker 1: then you'd have a super aspirin capable of being prescribed
- 19:21Speaker 1: much more often to even more people. Aspirin sales at
- 19:24Speaker 1: that point are already like fifty billion tablets per year,
- 19:28Speaker 1: So the amount of money on table for the first
- 19:30Speaker 1: pharmaceutical company to figure this out is mind boggling, because
- 19:33Speaker 1: then you get to patent it. Then you are the
- 19:35Speaker 1: only one that has the aspirin that doesn't cause stomach ulcers, right,
- 19:38Speaker 1: and for like whatever twenty years, you're the only one
- 19:40Speaker 1: who gets to sell that shit. That's so much fucking money, right, Like, yeah.
- 19:45Speaker 2: It's one of the most commonly used medications in the world.
- 19:47Speaker 1: Yes, or this is like an unfathomable fortune. We're talking
- 19:51Speaker 1: like an oil and gas industry level fortune is on
- 19:53Speaker 1: the table here, and so a fucking race begins, right,
- 19:58Speaker 1: And the two major companies that are going to wind
- 20:00Speaker 1: up really throwing their money, throwing their hats into the
- 20:02Speaker 1: table and to get into the super aspirin ring are
- 20:05Speaker 1: our old friend Pfizer and our new friend Merk. Now, today, again,
- 20:10Speaker 1: any pharmaceutical company you mentioned, people tend to say, like,
- 20:13Speaker 1: fuck these guys. But in the late nineteen eighties and
- 20:15Speaker 1: early nineties, people did not feel that way about Merk.
- 20:18Speaker 1: They were very much considered to be one of the
- 20:20Speaker 1: good guys. Now, I know that kind of sounds crazy,
- 20:23Speaker 1: but I want to read a quote from an article
- 20:24Speaker 1: by David Colp and Isabelle Berry in the Journal of
- 20:26Speaker 1: Civil Rights and Economic Development. In its missions value statement,
- 20:30Speaker 1: the company stresses that its business is preserving and improving
- 20:34Speaker 1: human life. Merk's mission statement continues, we value above all
- 20:37Speaker 1: the ability to serve everyone who can benefit from the
- 20:39Speaker 1: appropriate use of our products and services. Throughout its history,
- 20:43Speaker 1: Mirk has often lived up to its state admission. In
- 20:45Speaker 1: the nineteen thirties, after streptomycin was developed by a Merk scientist,
- 20:49Speaker 1: Merck gave up its patent protection since it believed the
- 20:52Speaker 1: drug was too important a medical breakthrough to keep to itself.
- 20:55Speaker 1: Other companies were allowed to produce streptomycin, and Merk lost
- 20:58Speaker 1: potential profits. The nineteen eighties, when Merk found a cure
- 21:01Speaker 1: for river blindness caused by a parasitic worm. The company
- 21:04Speaker 1: had given away, free of charge, forty million pillars a
- 21:07Speaker 1: year to African nations to treat and cure this. So
- 21:11Speaker 1: Merks seems pretty good. Coming into the nineties, You're like, hey,
- 21:14Speaker 1: maybe there's a company that I actually believes what it
- 21:16Speaker 1: is they put. They gave up money, you know, a
- 21:18Speaker 1: lot of it, so that sounds pretty great. But coming
- 21:21Speaker 1: into the nineties, Murk is also staring down the barrel
- 21:24Speaker 1: of a big problem a lot of its massive wealth,
- 21:27Speaker 1: because this is a very wealthy company coming into the nineties.
- 21:30Speaker 1: Was based on a pair of cholesterol drugs, zocore and Preachol,
- 21:34Speaker 1: which were both about to lose their twenty year patent
- 21:37Speaker 1: protection starting in the early two thousands, so not yet
- 21:39Speaker 1: in about a decade, but a Decade's not a lot
- 21:42Speaker 1: of time in terms of like researching a new medicine. Right,
- 21:45Speaker 1: If you've only got a decade or so over your
- 21:46Speaker 1: two big profit engines are going to.
- 21:49Speaker 4: Time from really to get to market. Yeah, you got
- 21:52Speaker 4: to start cooking. Yeah, you got to start moving. In
- 21:54Speaker 4: addition to that, five of their best selling medications, including pepsid,
- 21:58Speaker 4: were set to lose patent protection even soon in ninety nine,
- 22:01Speaker 4: so they are looking at a looming, very serious problem
- 22:05Speaker 4: for their profitability.
- 22:06Speaker 2: This is such a recurring theme with pharmaceutical companies. I
- 22:10Speaker 2: just did an episode about a medication called Zygris, which
- 22:14Speaker 2: was like, it sounds awesome, It sounds awesome. It's this
- 22:19Speaker 2: medication that was touted as like this new breakthrough therapy
- 22:23Speaker 2: for sepsis, and it was super exciting, ended up falling
- 22:27Speaker 2: apart for a lot of different reasons and being withdrawn
- 22:29Speaker 2: and end up being a big marketing scandal in my opinion.
- 22:32Speaker 2: But at the end of the day, it all started
- 22:34Speaker 2: because they were losing their patent on their big like
- 22:38Speaker 2: sellings and medications like the one, The things that were
- 22:40Speaker 2: making them tons of money were about to run out
- 22:43Speaker 2: and they needed a new like cash stream as quick
- 22:46Speaker 2: as possible. So things started happening probably faster than they
- 22:50Speaker 2: should have.
- 22:51Speaker 1: Yeah, yeah, yeah, And that's like that is the story
- 22:53Speaker 1: here as the story a lot of the time right
- 22:55Speaker 1: where these and I don't think this is a bad idea,
- 22:58Speaker 1: Like the idea that drugs eventually age out to get
- 23:00Speaker 1: generic is like kind of necessary in order to in
- 23:04Speaker 1: our system at least in order to make it even
- 23:07Speaker 1: have a chance of being affordable for some medications. But
- 23:10Speaker 1: it does it leads to this as well.
- 23:12Speaker 2: I don't know.
- 23:13Speaker 1: Again, we don't need to go on another single payer
- 23:16Speaker 1: healthcare rant, but like we have, so there's so many
- 23:18Speaker 1: little things that are fucked up about, like even the
- 23:21Speaker 1: things that seem like they make sense that also lead
- 23:24Speaker 1: to fucked up outcomes. And because of how much money
- 23:27Speaker 1: is at stake in these basins and how expensive it
- 23:30Speaker 1: is to be a pharmaceutical company, right, Like, it's not
- 23:33Speaker 1: cheap and most of the medications that they like, one
- 23:36Speaker 1: of the things you have to accept as a pharma
- 23:38Speaker 1: company is that most of the things you try to
- 23:40Speaker 1: make into a medicine aren't going to work, right, Like,
- 23:44Speaker 1: that's just and that's kind kind of the story. Here
- 23:46Speaker 1: is a medication that if they had done more, spent
- 23:49Speaker 1: more time, they would have realized this was not a
- 23:53Speaker 1: viable product. But they've got shareholders to please.
- 23:58Speaker 2: Right, and when the money start to shift from research
- 24:02Speaker 2: and development in these companies to marketing, which it does
- 24:05Speaker 2: more and more, and I.
- 24:06Speaker 1: Mean really happening in the nineties.
- 24:08Speaker 2: Yeah right, I'm assuming that's that their problem here, That's a.
- 24:12Speaker 1: Big part of it. Yes, so you know, murk is
- 24:16Speaker 1: coming into the nineties, not quite a five alarm fire yet,
- 24:19Speaker 1: but definitely like a serious situation. And super Aspirins seems
- 24:22Speaker 1: like it might be the salt solution to their problems
- 24:26Speaker 1: and maybe even the key to greater profits than ever before.
- 24:29Speaker 1: And speaking of greater profits than ever before, you know,
- 24:31Speaker 1: who's making money like they've never made money.
- 24:35Speaker 2: Oh, I'm the people who deserve to the people are
- 24:39Speaker 2: the people who sponsored this podcast. They're the ones that
- 24:41Speaker 2: deserve the most of the money.
- 24:42Speaker 1: That's right. The products and services that support this podcast
- 24:46Speaker 1: are literally the only ethical people in capitalism. And you
- 24:50Speaker 1: can just trust them. Give them your wallet, give your kids,
- 24:53Speaker 1: you know, hand with children over to our sponsors. They'll
- 24:56Speaker 1: take care of them, they'll raise them as their own.
- 24:58Speaker 1: You know better than better than we would, better than
- 25:00Speaker 1: you would. Yeah, exactly, you know, just trust them and
- 25:08Speaker 1: we're back. I didn't mean to imply that none of
- 25:11Speaker 1: you were good parents. It's just that our sponsors are
- 25:13Speaker 1: incredible parents, you know.
- 25:15Speaker 2: That much better.
- 25:16Speaker 1: They've never they've never yelled at me, never yelled at me,
- 25:19Speaker 1: never even spanked me, and I deserved it sometimes. So
- 25:24Speaker 1: you paid money for that sort of thing, I have. No,
- 25:28Speaker 1: we don't even saying shit like that. The subredit's gotta
- 25:31Speaker 1: get real uncomfortable, very fast. Okay, So super Aspirin seems
- 25:37Speaker 1: like it could be the solution to their to Merk's problems.
- 25:39Speaker 1: In nineteen ninety four, a new CEO takes over at Merk,
- 25:42Speaker 1: and this is we were just talking about the shift
- 25:45Speaker 1: from R and D to marketing. This is perfectly emblematic
- 25:48Speaker 1: of that because Merk's new CEO is a guy named
- 25:50Speaker 1: Raymond gil Martin. Now, the previous CEO, Raymond is an
- 25:54Speaker 1: NBA from Harvard, right, which means he doesn't know anything
- 25:58Speaker 1: about anything but making making money in the most sketchy
- 26:02Speaker 1: ways possible. Whereas the previous CEO of Merk had been
- 26:05Speaker 1: doctor Roy Vagelos, an actual medical scientist with a research background.
- 26:10Speaker 2: Very famous.
- 26:11Speaker 1: So yes, yes, yeah, so R goes from famous and
- 26:15Speaker 1: widely respected medical researcher as their CEO to a guy
- 26:19Speaker 1: with an MVA NBA from Harvard.
- 26:22Speaker 2: Yeah. The Vagelos Award is like this award that's still
- 26:26Speaker 2: given out to like people who are like doing humanitarian
- 26:30Speaker 2: work for like in the pharmaceutical world. So yeah, like
- 26:34Speaker 2: this is a major shift, a major shift away from
- 26:38Speaker 2: somebody who was I think ostensibly a very good person
- 26:41Speaker 2: from all the towns, a very good person, good researcher. Yeah,
- 26:44Speaker 2: to something very different.
- 26:46Speaker 1: Yeah. Maybe maybe the answer is, if you're going to
- 26:49Speaker 1: be the CEO of a pharmaceutical company, you should have
- 26:51Speaker 1: like watched a sick child die at a hospital. Like
- 26:55Speaker 1: I don't mean to be blunt, blunt, but it seems
- 26:58Speaker 1: like it leads you to do things like give up
- 27:00Speaker 1: patents on life saving medication.
- 27:03Speaker 2: For rotation, a rotation in the hospital.
- 27:06Speaker 1: I keep thinking about, like fucking the polio vaccine guy
- 27:10Speaker 1: who he was, like, I think his direct his direct
- 27:13Speaker 1: question quote when asked if he was going to patent
- 27:15Speaker 1: it was like would you patent the sun?
- 27:20Speaker 2: Yeah?
- 27:20Speaker 1: Sulk, yeah, real, real, real, g real Chad so Raymond's
- 27:26Speaker 1: career up to that point this is the business guy.
- 27:28Speaker 1: See new CEO Mark had included eight years as a
- 27:31Speaker 1: consultant for Arthur D. Little, which lists as run of
- 27:35Speaker 1: its great achievements, which is it. It's like Mackenzie kind of.
- 27:38Speaker 1: It's a consulting firm and it listed as one of
- 27:40Speaker 1: its great achievements the privatization of British rail So those
- 27:45Speaker 1: of you over in the UK, sure you love this guy. Also,
- 27:51Speaker 1: there was this time that they used a bucket of
- 27:53Speaker 1: sow's ears to make a silk purse. I don't know
- 27:56Speaker 1: why this is listed as an achievement of the Arthur D.
- 27:58Speaker 1: Little company, but it is. He worked as the CEO
- 28:02Speaker 1: at a medical device company after that, until he was
- 28:04Speaker 1: hired by Merck as their first outside CEO for the
- 28:08Speaker 1: express purpose of seeing them through the looming patent cliff scenario.
- 28:11Speaker 1: So he was brought in as kind of like an
- 28:12Speaker 1: emergency guy right now. It was Raymond who decided that
- 28:16Speaker 1: Merk's future would be in super aspirin. Alongside their chief scientist,
- 28:20Speaker 1: doctor Edward Skolnik, he launched a crash program to bring
- 28:24Speaker 1: a cox to inhibitor pain medication to market. The name
- 28:27Speaker 1: they picked for the wonder drug that did not yet exist,
- 28:30Speaker 1: but they were going to have that they were going
- 28:32Speaker 1: to hang the company's future on was Viox.
- 28:35Speaker 2: Now.
- 28:35Speaker 1: Time was of the essence here. Doctor Needleman, the guy
- 28:38Speaker 1: who had failed to discover Cox two but had gone
- 28:41Speaker 1: ahead and named it anyway, worked at a company called
- 28:43Speaker 1: g D. Seerle which was a division of Monsanto and
- 28:47Speaker 1: was leading research into a new inside that would eventually
- 28:50Speaker 1: be called Celebrex. And while Celebrex was under development, Pfizer
- 28:54Speaker 1: bought Seerrel from Monsanto and started throwing money into Celebrex
- 28:59Speaker 1: as part of what was turning into a vicious competition
- 29:01Speaker 1: to be the first pharmaceutical company to bring one of
- 29:04Speaker 1: these new super aspirints to market. And there's probably a
- 29:07Speaker 1: lot to be said about Celebrex. I am not competent
- 29:10Speaker 1: to say it. I will say that it is currently
- 29:12Speaker 1: a medication that the FDA says there's not evidence of
- 29:17Speaker 1: significant harms for There is debate about that to this day.
- 29:20Speaker 1: But that's all I can say on the matter because
- 29:23Speaker 1: I'm not a not an expert on this. There are
- 29:25Speaker 1: some activists who are very angry that Celebrex is still
- 29:28Speaker 1: on the market. The FDA has said it's more or
- 29:30Speaker 1: less fine. That's where we are with Celebrex.
- 29:33Speaker 2: Yeah, it's the same family, Yes, and it does have
- 29:37Speaker 2: that comes with a warning on it that's more striking
- 29:40Speaker 2: than most other ensades. Yes, I know. Actually it's a
- 29:44Speaker 2: good question. I don't know how often it's used these days.
- 29:46Speaker 1: I assume it's pretty rare or not as often as
- 29:50Speaker 1: it was.
- 29:51Speaker 2: For sure.
- 29:51Speaker 1: It's one of those things where a few years ago
- 29:53Speaker 1: there was a very scary study about heart effect like
- 29:56Speaker 1: heart problems that it could cause, and then a few
- 29:59Speaker 1: years later there was a study that suggests like, well, no,
- 30:01Speaker 1: maybe we got that one wrong. Maybe it's no worse
- 30:03Speaker 1: than other drugs in this class. Again, that's all I
- 30:06Speaker 1: can really say about Celebres because I'm not qualified to
- 30:11Speaker 1: judge a medication that there's still a lot of debate over.
- 30:14Speaker 2: I don't have a lot more to add to it either,
- 30:16Speaker 2: But it feels like there's other ensades out there that, yes,
- 30:19Speaker 2: that we use a little frequently. It seem a little safer. Yeah.
- 30:22Speaker 1: Yeah, But what you need to know is that Pfiser
- 30:25Speaker 1: is putting there, is putting their money into Celebres after
- 30:29Speaker 1: they acquire Merle, and you know vox is going to
- 30:34Speaker 1: be the attempt made by Mark to do the same thing.
- 30:38Speaker 1: So throughout the mid nineteen Ninetieskvet Merk scientists worked on VOCs,
- 30:42Speaker 1: rushing it through stages of medical testing, harassed by the
- 30:45Speaker 1: knowledge that any delay or bad finding. And when I
- 30:48Speaker 1: say bad, not in a scientific sense. It's not bad
- 30:50Speaker 1: scientifically to find out a drug doesn't work, but bad
- 30:53Speaker 1: for the company if this drug doesn't work because they're
- 30:55Speaker 1: on a timetable, would stop them from beating Pfizer and
- 30:59Speaker 1: unfortunately forever. There were signs right from the beginning that
- 31:02Speaker 1: viox might be dangerous. The first evidence of this was
- 31:06Speaker 1: presented in the mid nineteen nineties by doctor Garrett Fitzgerald,
- 31:09Speaker 1: a Merck consultant who was also professor of cardiovascular medicine
- 31:13Speaker 1: at the University of Pennsylvania. He warned the company that
- 31:16Speaker 1: Vyax might harm the walls of the blood vessels protecting
- 31:19Speaker 1: the human heart. I'm going to quote again from the
- 31:21Speaker 1: book Poison Pills by Tom NeSSI, which, if you're looking
- 31:23Speaker 1: for like a really good exploration of how a pharmaceutical
- 31:26Speaker 1: company does evil, Poison Pills is very well written. He
- 31:30Speaker 1: suggested that Mark set up a series of experiments to
- 31:32Speaker 1: test this theory, few of them wherever performed. Other scientists
- 31:35Speaker 1: cautioned that yox was related to kidney damage an increase
- 31:38Speaker 1: in blood pressure that could be linked to heart problems.
- 31:41Speaker 1: Doctor Fitzgerald also found similar problems with the drug in
- 31:44Speaker 1: the same class as vyax, called Celebres, made by rival
- 31:46Speaker 1: drug company Pfiser. Like Merk, Pfeiser denied the finding of
- 31:49Speaker 1: any cardiovascular problems with its drug, but cleverly began its
- 31:53Speaker 1: own campaign to portray viox as the more dangerous of
- 31:56Speaker 1: the compounds. That's smart at this point and victually warns
- 32:00Speaker 1: them the drug is not on market. He is trying
- 32:02Speaker 1: to stop it from getting to market by saying, like,
- 32:04Speaker 1: there's some real evidence. This is sketchy, you should carry
- 32:06Speaker 1: it more studies, and Murk is just kind of like,
- 32:09Speaker 1: but what if we didn't.
- 32:13Speaker 2: It's like when you've.
- 32:14Speaker 1: Been like spending like crazy all month, and you know,
- 32:16Speaker 1: you probably like you might be running down to the limit,
- 32:18Speaker 1: but you're just like going to the grocery store hoping
- 32:20Speaker 1: that like your card works this one more time or something.
- 32:24Speaker 1: So now, at this point, there was no hard evidence
- 32:28Speaker 1: of harm to the human heart, in large part because
- 32:30Speaker 1: Merk had refused to do the studies that doctor Fitzgerald advised.
- 32:33Speaker 1: This changed in nineteen ninety six, when an internal Mirk
- 32:36Speaker 1: study showed that people who took viox in high doses
- 32:39Speaker 1: suffered more heart problems than people given a placebo. A
- 32:43Speaker 1: MIMO was issued internally that noted the treatment period was
- 32:46Speaker 1: six weeks versus placebo. The initial dose of viox was
- 32:49Speaker 1: one hundred and seventy five milligrams, but in mid study
- 32:52Speaker 1: the dose was lowered to one hundred and twenty five milligrams.
- 32:54Speaker 1: Adverse events of most concern were in the cardiovascular system
- 32:58Speaker 1: i e. Heart attack, stable angina, rapid fallen hemoglobin and
- 33:02Speaker 1: hematopec crip, dangerous blood problems and some subjects. So that's bad.
- 33:07Speaker 1: Those are all really bad. Yeah, results, that's yeah.
- 33:10Speaker 2: You're almost officially a doctor because that is correct. That
- 33:13Speaker 2: is the appropriate diagnosis is that it's all not good,
- 33:16Speaker 2: not good, not good, not good.
- 33:19Speaker 1: It is important to underline the severity of these results, though.
- 33:22Speaker 1: These extremely serious side effects were present after just a
- 33:25Speaker 1: few weeks of medication for doses that were just about
- 33:29Speaker 1: twice the approved amount for treating acute pain, which was
- 33:32Speaker 1: fifty milligrams now twice sounds like a lot, but when
- 33:35Speaker 1: we are talking about the way people use medicines, it's
- 33:39Speaker 1: really not. People take way more, specially pain medicine than
- 33:43Speaker 1: they ought to.
- 33:45Speaker 2: It keeps me in business. Yeah, people do this. This
- 33:48Speaker 2: is like almost You don't even have to take it
- 33:52Speaker 2: more than is recommended to run into problems, because sometimes
- 33:55Speaker 2: people only take a little and they run into problems
- 33:57Speaker 2: in the GI system for example, or other issues that
- 34:00Speaker 2: kid needed that can be affected for the heart. But
- 34:04Speaker 2: it is a sole underlying known fact that whatever we
- 34:10Speaker 2: think people are going to be taking, likely it'll be.
- 34:13Speaker 1: More, and that is why it's standard in tests like
- 34:16Speaker 1: the one they were conducting, actually to test ten times
- 34:19Speaker 1: the effective acute dose when doing studies like this to
- 34:22Speaker 1: check for side effects, which they didn't do because they
- 34:25Speaker 1: knew that the results would be even worse. One doctor
- 34:28Speaker 1: who analyzed these results noted, I recall very clearly many
- 34:31Speaker 1: occasions where MERK scientists and doctors working with MERK were
- 34:34Speaker 1: claiming that viox was safe as placebo, which we've already
- 34:38Speaker 1: seen it's not.
- 34:40Speaker 2: Now.
- 34:40Speaker 1: The reality is that results like this were a big
- 34:43Speaker 1: warning sign and should have been taken as evidence that
- 34:45Speaker 1: biax might not be viable as a medication and certainly
- 34:48Speaker 1: needed more testing, But Merk went full speed ahead. In
- 34:50Speaker 1: November of nineteen ninety eight, they asked the FDA to
- 34:53Speaker 1: approve viviocs after testing the drug on fifty four hundred patients.
- 34:57Speaker 1: They bragged that they had conducted eight different studies which
- 34:59Speaker 1: had shown owned biox's efficacy. Now, this is where we
- 35:02Speaker 1: get into a complicated and uncomfortable topic, medical studies, and
- 35:06Speaker 1: why they often don't work the way that they should.
- 35:09Speaker 1: In theory, the process of conducting medical studies should identify
- 35:12Speaker 1: dangers in new drugs and accurately measure their efficacy. But
- 35:15Speaker 1: theory envisions a situation in which drugs are researched by
- 35:19Speaker 1: disinterested parties who have no vested interest in anything but
- 35:22Speaker 1: the truth. The reality is that studies are often funded
- 35:26Speaker 1: by pharmaceutical companies who, like Merk, might be sweating the
- 35:30Speaker 1: arrival of an upcoming patent cliff and headed by a
- 35:32Speaker 1: new CEO who lacks the same commitment to medical ethics
- 35:35Speaker 1: as his precursor. I'm going to quote now from an
- 35:38Speaker 1: article on this in the Union of Concerned Scientists to
- 35:41Speaker 1: increase the likelihood of FDA approval for its anti inflammatory
- 35:44Speaker 1: and arthritis drug bios. Merk used flawed methodologies biased towards
- 35:48Speaker 1: predetermined results to exaggerate the drug's private positive effects. Internal
- 35:52Speaker 1: documents made public in litigation revealed that a Merk marketing
- 35:55Speaker 1: team had developed a strategy called Advantage Assessment of Differences
- 35:58Speaker 1: between bios and to ascertain gastrointestinal tolerability and effectiveness to
- 36:03Speaker 1: skew the results of clinical trials in the drugs favor.
- 36:06Speaker 1: As part of the strategy, scientists manipulated the trial design
- 36:09Speaker 1: by comparing to the drug to neproxin, a pain reliever
- 36:12Speaker 1: sold under brand names such as a Leave, rather than
- 36:15Speaker 1: to a placebo. The scientists then highlighted the results that
- 36:19Speaker 1: neproxyen decreased the risk of heart attack by eighty percent
- 36:22Speaker 1: and downplayed the results that viax increased the rate the
- 36:25Speaker 1: risk of heart attack by four hundred percent. This misleading
- 36:28Speaker 1: presentation of the evidence made it looked like the proxen
- 36:30Speaker 1: was protecting patients from heart attacks and that vax only
- 36:33Speaker 1: looked risky by comparison. So instead of comparing this drug
- 36:37Speaker 1: to a placebo in which it would have been like Wow,
- 36:39Speaker 1: the rate of heart attacks is much higher. They compared
- 36:41Speaker 1: it to a drug that reduced the risk of heart
- 36:43Speaker 1: attacks and were like, well, of course people have more
- 36:45Speaker 1: heart attacks on this drug. This other drug reduces heart attacks,
- 36:49Speaker 1: but that doesn't mean this is danger. Like that's so
- 36:51Speaker 1: fucking shady.
- 36:54Speaker 2: Is It's a bit tricky how they're doing it too,
- 36:56Speaker 2: because you know, so far, a lot of what they
- 36:59Speaker 2: have done sounds very I mean it sounds sound from
- 37:02Speaker 2: a distance. You know, the whole idea of like looking
- 37:06Speaker 2: at COX two inhibitors, like looking at medications specifically for
- 37:09Speaker 2: this and comparing it, you know, say, hey, look at
- 37:12Speaker 2: least we're better than the other medications to some degree.
- 37:16Speaker 2: From a high from your way back vantage point, it
- 37:19Speaker 2: all makes sense. It's when you start to like look
- 37:21Speaker 2: a little bit more closely that it's questionable, especially given
- 37:27Speaker 2: that they seem to know early on that there was
- 37:29Speaker 2: high risk of these cardiovascular injuries and that the whole
- 37:33Speaker 2: narrative is being shifted to try and take focus away
- 37:36Speaker 2: from that. Yeah, it's it's all. This is why it's
- 37:40Speaker 2: a difference between marketing and between like a scientist running
- 37:43Speaker 2: the program. Yeah.
- 37:45Speaker 1: Yeah, and that's like that's really the whole story here, right.
- 37:49Speaker 1: So Merks fuckery extended to the hiring of ghostwriters to
- 37:53Speaker 1: write scientific articles reporting on clinical trials of bias to
- 37:56Speaker 1: try and convince doctors and regulators that the medication was safe.
- 38:00Speaker 1: Internal Mirk documents later revealed that in sixteen out of
- 38:03Speaker 1: twenty papers reporting on early VYAX clinical trials, a Merk
- 38:07Speaker 1: employee was listed as the lead author of the first draft,
- 38:10Speaker 1: but in the published versions credit for authorship was given
- 38:14Speaker 1: to an outside academic to continue in that from that
- 38:17Speaker 1: piece by the Union of Concerned Scientists. In one draft
- 38:20Speaker 1: of a Yox research study that did not yet have
- 38:22Speaker 1: a prominent outside name attached, MIRK officials listed the lead
- 38:25Speaker 1: author only as external author question mark. A MERK scientist
- 38:30Speaker 1: was also found to have removed the evidence of free
- 38:32Speaker 1: heart attacks among patients in a data set from the
- 38:35Speaker 1: results presented some great stuff.
- 38:39Speaker 2: I mean, in wonder what numbers were in that paper,
- 38:42Speaker 2: but removing three can make a huge difference.
- 38:44Speaker 1: Yes, yes, especially if you're not talking about a huge study.
- 38:47Speaker 2: You know, did say anything about how many people were
- 38:50Speaker 2: in that study?
- 38:51Speaker 1: I you know what, I'm sure I could have looked
- 38:53Speaker 1: into it, but I did not.
- 38:56Speaker 2: And I'm wondering if in these studies they were talking
- 38:58Speaker 2: about the rates of ulcer bleed and gastric bleeding as well,
- 39:02Speaker 2: because I mean that's o sensibly the whole reason that.
- 39:05Speaker 1: They're doing it was the whole thing that advantage was
- 39:07Speaker 1: supposed to show, right, is that it reduced the rate
- 39:10Speaker 1: of like peptic ulcer bleeding and stuff. And yeah, just
- 39:12Speaker 1: the whole the fact that we have drafts of them
- 39:15Speaker 1: just being like, we'll figure out who the author of
- 39:17Speaker 1: this piece is later, once we find a science, once
- 39:19Speaker 1: we find an outside doctor who you know, wants some cash.
- 39:23Speaker 1: And a lot of times these aren't direct bribes. These
- 39:25Speaker 1: are like, okay, you'll stick your name on this and
- 39:28Speaker 1: then this research project you want, we'll get a little
- 39:30Speaker 1: bit of funding from a from from a Papa merk.
- 39:33Speaker 2: You know. Not even just that these are all being
- 39:35Speaker 2: published in decent journals. I'm sure that just people want
- 39:39Speaker 2: to be in good journals. They want to have another
- 39:41Speaker 2: publication and you know, New Journal and Medicine or the
- 39:44Speaker 2: Lancet or whatever.
- 39:46Speaker 1: And you you also have to remember people think a
- 39:48Speaker 1: lot of people think this is the next big miracle drugs.
- 39:50Speaker 1: So yeah, you want you want to you want to
- 39:52Speaker 1: have a you want to have a little bit of
- 39:53Speaker 1: play in that, right of course.
- 39:56Speaker 2: Uh so. Yeah.
- 39:57Speaker 1: The worst piece of evidence against BIOS of this peerod
- 40:00Speaker 1: came out the same year Merk asked for FDA approval
- 40:02Speaker 1: nineteen ninety eight. Merk Study zero ninety involved nine hundred
- 40:06Speaker 1: and seventy eight patients and showed that people on BIOS
- 40:09Speaker 1: experienced serious cardiovascular events six times as often as patients
- 40:12Speaker 1: taking a different drug or a placebo for arthritis pain.
- 40:16Speaker 1: Merks shelled the study and never published it. Later that
- 40:19Speaker 1: same year, a group of medical researchers at the University
- 40:22Speaker 1: of Pennsylvania and by the way, thanks to that doctor
- 40:25Speaker 1: we named earlier, U of pen really tried to stop
- 40:27Speaker 1: biox from being a thing, published a study that showed
- 40:31Speaker 1: that COX two inhibitors might interfere with other enzymes that
- 40:34Speaker 1: helped prevent heart disease. Warnings were sent to Mercandfiser, who
- 40:38Speaker 1: quickly shoved them off into the circular file and kept
- 40:41Speaker 1: right on begging the FDA to say yes. And say yes,
- 40:44Speaker 1: the FDA did. They approved bios for use as a
- 40:47Speaker 1: painent killer in results in adults in nineteen ninety nine.
- 40:51Speaker 1: A minstrel pain medication and an anti inflammatory for people
- 40:54Speaker 1: with osteoarthritis. Despite approving the drug, FDA reviewer doctor Villalba
- 40:59Speaker 1: warned in his memorandum that there was evidence suggesting vyax
- 41:02Speaker 1: caused more frequent cardiovascular events and patients. So Vox goes
- 41:08Speaker 1: to market, it immediately becomes a best seller. Celebrex also
- 41:12Speaker 1: goes to market. It drives massive profits for Pfizer. And
- 41:15Speaker 1: this is in spite of the fact that particularly viox
- 41:18Speaker 1: is not great at I mean, neither drug is really
- 41:21Speaker 1: all that good at fighting pain. And I'm going to
- 41:23Speaker 1: quote from the New York Times here. When studies on
- 41:25Speaker 1: viox and rex became available in nineteen ninety eight nineteen
- 41:28Speaker 1: ninety nine, many doctors were disappointed. Neither drug alleviated pain
- 41:32Speaker 1: any better than the old medications, and the drugs cost
- 41:35Speaker 1: close to three dollars a pill over the counter. Pain relievers,
- 41:38Speaker 1: in contrast, cost pennies a dose, and by the way,
- 41:42Speaker 1: they weren't all that much better at preventing ulcers. Some
- 41:45Speaker 1: studies suggest like viox was no better at preventing ulcers,
- 41:48Speaker 1: although that seems to be unclear now. Analysts say that
- 41:51Speaker 1: the success of viox was critical to MRK. The patents
- 41:55Speaker 1: on those popular mark drugs Aspire started expiring in two
- 41:57Speaker 1: thousand and two thousand and one, which opened them up
- 41:59Speaker 1: to eric competition, and Vyox comes through and is I
- 42:04Speaker 1: mean almost immediately billions of dollars a year in profits
- 42:07Speaker 1: for the company. Michael krint Savage, a drug industry analyst
- 42:11Speaker 1: at the investment bank Raymond Jameson Associates, says vax was
- 42:14Speaker 1: Merk savior. It's as simple as that, like he puts
- 42:17Speaker 1: it down, as the company might have gone on or
- 42:19Speaker 1: under at least, you know, probably been acquired if it
- 42:21Speaker 1: hadn't been for a Yox.
- 42:23Speaker 2: I mean, I remember at the time it was huge.
- 42:26Speaker 2: It was I had never seen a campaign like it
- 42:30Speaker 2: about that I remember. I think it was one of
- 42:31Speaker 2: the first times I remember really having like being conscious
- 42:36Speaker 2: of like how much a medicine was being marketed, you know.
- 42:41Speaker 2: And you know, I think it's one of these medicines
- 42:44Speaker 2: where it's like, you know, maybe five to ten percent
- 42:47Speaker 2: of the people who are using it maybe had some benefit,
- 42:49Speaker 2: real benefit where they maybe it did help them from
- 42:52Speaker 2: a gastric ulcer perspective, maybe they didn't have the option
- 42:56Speaker 2: of taking another medicine. But for the other ninety percent
- 42:59Speaker 2: of people there taking it, it wasn't necessary for them.
- 43:03Speaker 2: It wasn't something that they needed, and it was just
- 43:04Speaker 2: increasing their risk of heart attack or stroke. And I
- 43:08Speaker 2: think that this is I bet you. I mean, you
- 43:11Speaker 2: probably know this, but I bet up to this point
- 43:13Speaker 2: this was the most that ever been spent on direct marketing.
- 43:17Speaker 1: Yeah, I mean, and that is what we're actually about
- 43:19Speaker 1: to talk about is the marketing campaign, which surprise, surprise,
- 43:22Speaker 1: involves beloved figure skater Dorothy Hamill.
- 43:26Speaker 2: But I knew it.
- 43:27Speaker 1: Yes, she's the great monster in this in all of
- 43:31Speaker 1: our episodes, every episode we have ever done, Dorothy Hamill
- 43:34Speaker 1: and building into this.
- 43:35Speaker 2: She's the fanos of the behind the Bastard's world.
- 43:37Speaker 1: That's right. Joseph Stalin would never have accomplished his greatest
- 43:40Speaker 1: crimes without Dorothy Hamill's assistance. That's obvious though. Evil historians
- 43:45Speaker 1: have been talking about that for decades. Anyway, you know
- 43:48Speaker 1: who's not Dorothy Hamill. I don't know why I'm shitting
- 43:51Speaker 1: on Dorothy Hamill. None of this is really her fault. Anyway,
- 43:53Speaker 1: here's as we're back. Okay, so we're talking the viox
- 44:04Speaker 1: marketing campaign. How do you sell America on this drug
- 44:07Speaker 1: that is going to get a decent percentage of America killed?
- 44:11Speaker 1: And the answer is figure skating superstar Dorothy Hamill. So yeah,
- 44:17Speaker 1: this is this is where the real villain of the
- 44:19Speaker 1: story comes into it.
- 44:21Speaker 2: The haircut is a problem for me.
- 44:22Speaker 1: I had Hamil's haircut.
- 44:24Speaker 2: My first girlfriend, The first girl that really smashed my
- 44:29Speaker 2: heart into like a billion pieces, scattered them across the globe.
- 44:32Speaker 1: Was Dorothy Hamill. That has really taking some strays in
- 44:35Speaker 1: this episode.
- 44:36Speaker 2: Just she had Dorothy Hamill's haircut. Oh, which I don't
- 44:41Speaker 2: know why at the time didn't bother me, But so
- 44:45Speaker 2: now when I see that haircut, I'm like, oh, yeah,
- 44:47Speaker 2: that reminds.
- 44:47Speaker 1: Me of that that lost love.
- 44:51Speaker 2: Yeah, painful, painful. So for those of you.
- 44:53Speaker 1: Who don't know what we're talking about, back in the
- 44:55Speaker 1: nineteen seventies, an incredible athlete named Dorothy Hamill became one
- 44:59Speaker 1: of the most famous people in the world. When she
- 45:00Speaker 1: was just nineteen. She performed at the nineteen seventy six
- 45:03Speaker 1: Innsbruck Olympics and won the gold. Time declared her America's
- 45:07Speaker 1: Sweetheart and as his customary for world class athletes, corporations
- 45:10Speaker 1: began offering her embarrassing piles of money to endorse their products.
- 45:15Speaker 1: Hamil's first run as a famous person didn't go great.
- 45:18Speaker 1: She married Dean Martin's kid, and then he died in
- 45:21Speaker 1: a plane crash. She fell out with her coach. She
- 45:24Speaker 1: spent all of her money buying the ice capades, and
- 45:26Speaker 1: then wound up burning out and developing a bleeding ulcer.
- 45:30Speaker 1: She had another marriage that ended badly and wound up well,
- 45:32Speaker 1: not broke, you wouldn't say, but no longer rich, and
- 45:36Speaker 1: she suffered from a substantial amount of pain from a
- 45:38Speaker 1: lifetime of pushing her body to athletic excess. The pain
- 45:42Speaker 1: was bad enough that at the worst Dorothy could no
- 45:44Speaker 1: longer even play with her daughter. Some days she could
- 45:47Speaker 1: barely get out of bed. And then her doctor told
- 45:49Speaker 1: her to try biox. She would later claim that it
- 45:52Speaker 1: was effectively a miracle cure for her, not only soothing
- 45:55Speaker 1: her pain, but bringing back her ability to perform on
- 45:58Speaker 1: the ice in a way she hadn't in years. In
- 46:01Speaker 1: August of two thousand, Hamil made an appearance on Larry
- 46:03Speaker 1: King Live with Caitlyn Jenner, and Jenner is also talking
- 46:06Speaker 1: about viox and this this. Jenner is also claiming that
- 46:09Speaker 1: like this this really helped her arthritis. She told the
- 46:13Speaker 1: audience a heart wrenching story about loss and pain and
- 46:16Speaker 1: her miraculous return to the world of the living thanks
- 46:18Speaker 1: to Vyos quote. I just I felt old. I felt depressed,
- 46:23Speaker 1: tired all the time. I mean, having chronic pain is exhausting.
- 46:26Speaker 1: And I got to the point this year I was
- 46:27Speaker 1: on tour and I couldn't skate, and so I went
- 46:30Speaker 1: to a doctor and we finally got to the bottom
- 46:32Speaker 1: of it, and my doctor prescribed VOX for me. And
- 46:34Speaker 1: it's as if I've been given a new life. It's
- 46:36Speaker 1: just it's been amazing. I feel twenty years younger. I
- 46:39Speaker 1: don't look it, and I don't skate it, but I
- 46:41Speaker 1: feel that way.
- 46:43Speaker 2: Was this when Larry King still had some credibility?
- 46:45Speaker 1: Oh yeah, he was big at this point. This is
- 46:48Speaker 1: like right around the turn of the century. He's still
- 46:50Speaker 1: a big, a major major. This is like before infomercial
- 46:55Speaker 1: Larry Yes, yes, okay, and this is I mean, maybe
- 46:58Speaker 1: this is part of his downfall. But people still take
- 47:01Speaker 1: the show series and they take this very seriously. And
- 47:02Speaker 1: to be clear, I'm not saying that, you know, even
- 47:05Speaker 1: Caitlin or or Hamilorthy were lying about their experiences on
- 47:12Speaker 1: viox because some people did gain benefits of this. Yeah,
- 47:16Speaker 1: and you know, so I'm not doubting that. The problem
- 47:18Speaker 1: again is that a single person's having a good reaction
- 47:22Speaker 1: to a drug is not evidence that the drug is safe.
- 47:25Speaker 3: You know.
- 47:26Speaker 1: For example, I know some people in their seventies who
- 47:29Speaker 1: have been doing heroin for fifty straight years and are
- 47:32Speaker 1: and are fine. That doesn't mean heroin is safe. It
- 47:36Speaker 1: means some people are lucky, right, Yeah, or they afore
- 47:41Speaker 1: mentioned ninety year old women doing you know.
- 47:44Speaker 2: Those ancient people who do you get drugs and smokes
- 47:47Speaker 2: that you now with a.
- 47:48Speaker 1: Little burning Man regionals, you run into a lot of
- 47:50Speaker 1: elderly people who have been doing drugs for forever. Some
- 47:54Speaker 1: of them are very good at it. I've been gas
- 47:58Speaker 1: stations sober for years now, Kava, that's Responlifornia sober.
- 48:03Speaker 2: But you can only get the things you buy at
- 48:06Speaker 2: the gas station.
- 48:06Speaker 1: I don't mess with that marijuana. That shit's dangerous. I
- 48:09Speaker 1: just take those trucker yellow jackets that they give to
- 48:11Speaker 1: keep people driving long haul awake. You know, I don't
- 48:15Speaker 1: know what's in them. They're big and yellow. That means
- 48:17Speaker 1: they're safe. Yeah, it's danger'd me red if it was dangerous.
- 48:22Speaker 1: They can't put dangerous drugs in a yellow and black
- 48:25Speaker 1: pill and call it yellow jackets and it doesn't mean dangerous.
- 48:28Speaker 2: Yeah.
- 48:29Speaker 1: So I never take more than like twelve in a day. Yeah,
- 48:32Speaker 1: thank god for yellow jackets.
- 48:35Speaker 2: I just some I sometimes don't know if you're kidding,
- 48:39Speaker 2: and I just hope in my heart that you are.
- 48:41Speaker 2: And I'm just going to pretend that this is all
- 48:44Speaker 2: part of a bit.
- 48:45Speaker 1: I do the safe thing. I like, open the pill
- 48:47Speaker 1: and I pour all the powder in the pill into
- 48:49Speaker 1: a glass, and then I pour in a bunch of
- 48:50Speaker 1: my krateion into the glass, and then I add a
- 48:52Speaker 1: banana for the potassium because your heart level.
- 48:56Speaker 2: This level of detail is what bothers me.
- 49:01Speaker 1: The more I don't like it's fine. It's mostly just
- 49:05Speaker 1: B twelve in caffeine and god knows what else, because
- 49:07Speaker 1: there's absolutely no no agency that looks into what gets
- 49:11Speaker 1: put into substances that are sold in gas stations in
- 49:13Speaker 1: this country.
- 49:14Speaker 2: Oh my god, and what little oversight there is is
- 49:17Speaker 2: gonna be gone.
- 49:18Speaker 1: Yes, thanks gone, thank god. Look, RFK Junior might ban
- 49:22Speaker 1: the HPV vaccine, but we could get legal heroin.
- 49:29Speaker 2: It's all one big, organized end of humanity cash grab
- 49:34Speaker 2: the next couple of years. Any drug you want to
- 49:37Speaker 2: get through is gonna get through god willing.
- 49:41Speaker 1: Look, if the world's ending, do you want heroin to
- 49:44Speaker 1: not be legal?
- 49:47Speaker 2: That's fair, But it's not gonna be heroin. It's gonna
- 49:50Speaker 2: be like, you know, blood pressure pills that the company
- 49:54Speaker 2: just gets through and then it makes people's hearts explode,
- 49:58Speaker 2: and then the company will just say, hey, we're bank
- 50:00Speaker 2: and then they're fine, and then they just move on
- 50:02Speaker 2: with their lives, and then people are going to be
- 50:04Speaker 2: left in the wake.
- 50:05Speaker 1: Then no, you're right, they're going to ban prozac and
- 50:08Speaker 1: replace it with like polar Bear liver pills. It's just
- 50:12Speaker 1: going to be a disaster.
- 50:14Speaker 2: He was always doing research that in RFK.
- 50:16Speaker 1: He's always trying something new. So the fact that this
- 50:21Speaker 1: beloved celebrity athlete has gone on Larry King and said
- 50:24Speaker 1: exactly what viox PR would want her to say was
- 50:28Speaker 1: a godsend. You know, that's the kind of pr no
- 50:30Speaker 1: money can buy. Although I have to tell you now
- 50:33Speaker 1: that moment was in fact bought and paid for by
- 50:35Speaker 1: MERK they had found out that Dorothy was a customer.
- 50:39Speaker 1: They had reached out to her with an idea and
- 50:41Speaker 1: a pile of money. Her life story had been used
- 50:44Speaker 1: as the basis for an entire marketing campaign, and her
- 50:47Speaker 1: appearance on Larry King was just the first step in
- 50:49Speaker 1: launching it. Tom NeSSI writes the day after Dorothy Hamill's appearance,
- 50:53Speaker 1: even Merks CEO Raymond gil Martin was smitten. He received
- 50:56Speaker 1: heart written letters from arthritis sufferers saying they were going
- 50:59Speaker 1: to immediately ask their physicians for a viox. Gil Martin
- 51:02Speaker 1: personally congratulated the public relations department. One marketing executive wrote
- 51:06Speaker 1: that with Dorothy telling our story, vyox sales were going
- 51:09Speaker 1: to soar and overtake celebrates and obsession within the.
- 51:12Speaker 2: You'll slipped into like your fifties radio announcer voice. You
- 51:16Speaker 2: kind of shifted to the nineties. I saw what you
- 51:18Speaker 2: did there.
- 51:19Speaker 1: I love it. I love it. I love it. So yeah,
- 51:22Speaker 1: patients are are coming in, They're begging doctors to write prescriptions.
- 51:25Speaker 1: Doctors are going, well, shit, how bad could it be.
- 51:28Speaker 1: It's basically just aspirin, you know, And a lot of
- 51:32Speaker 1: people are suddenly taking viox. Now the FDA does push
- 51:35Speaker 1: back a little on this campaign because Dorothy's appearance on
- 51:38Speaker 1: Larry King counted as an ad and she had not
- 51:41Speaker 1: mentioned that she was being paid by Merk, which you're
- 51:44Speaker 1: not supposed to do. They also had an issue that
- 51:49Speaker 1: she was kind of basically saying she had not told
- 51:52Speaker 1: people that viox was extremely dangerous if you prescribed it
- 51:55Speaker 1: to patients with the history of bleeding ulcers. In fact,
- 51:58Speaker 1: she had stated that she was taking it despite her
- 52:01Speaker 1: history of bleeding ulcers, which is kind of telling people
- 52:04Speaker 1: this is safe to say in the exact situation that
- 52:07Speaker 1: the FDA knows. We know it is not safe to
- 52:10Speaker 1: tell people to take it in. So the FDA gets
- 52:13Speaker 1: kind of unhappy with this, and Merk replied, she just
- 52:15Speaker 1: slipped up. We taught Hammil the proper way to sell
- 52:18Speaker 1: our product, but she went off script. They promised to
- 52:22Speaker 1: retrain her before following up with any additional advertisements. This
- 52:26Speaker 1: happened on September twelfth, two thousand. The next day, in
- 52:29Speaker 1: violation of their promise to the FDA, Hamill appeared on
- 52:32Speaker 1: a local TV station in Atlanta to urge people to
- 52:35Speaker 1: consider a biox. The FDA never found out about this
- 52:38Speaker 1: and might not have cared if they had, if you
- 52:39Speaker 1: wanted to get away with something. September twelfth, will actually
- 52:42Speaker 1: that was two thousand. Never mind, everything was still fine.
- 52:46Speaker 1: I was gonna. I was just like, did I just
- 52:47Speaker 1: go over to September twelfth and not make it?
- 52:49Speaker 2: I feel like that. No, No, it's fine.
- 52:51Speaker 1: Research didn't happen yet, everything was fine. Plenty of towers
- 52:54Speaker 1: in New York still at this now. The unfortunate reality
- 52:58Speaker 1: of the FDA is that it is stand and operated
- 53:00Speaker 1: by a lot of people who want to work in
- 53:02Speaker 1: the private sector of the pharmaceutical industry someday, and some
- 53:06Speaker 1: of these people feel a need to avoid making waves
- 53:08Speaker 1: and killing a golden goose that is currently injecting cash
- 53:11Speaker 1: into someone they want as a future employer who made
- 53:14Speaker 1: a bit of past employer that they're hoping we'll hire
- 53:17Speaker 1: them on for a lucrative consulting gig in the future.
- 53:19Speaker 1: Beyond that, the teams at the FDA who we rely
- 53:22Speaker 1: on to monitor food and drug advertising are hideously understaffed,
- 53:25Speaker 1: operating on a shoe string budget. There may not have
- 53:28Speaker 1: been anyone watching Dorothy Hamill's ad on local Atlanta TV
- 53:31Speaker 1: because no one was being paid to do so. Now,
- 53:34Speaker 1: MERK did change their TV ads for vyox based on
- 53:37Speaker 1: the FDA's feedback, and you can see one example of
- 53:39Speaker 1: that here. We've got to play just one of these
- 53:41Speaker 1: bad boys. Here is Dorothy Hamill's revised vyox ad.
- 53:46Speaker 5: When I started skating at eight years old, I never
- 53:49Speaker 5: thought i'd experience the thrill of winning a medal with
- 53:52Speaker 5: all the great memories. Has come another thing I thought
- 53:54Speaker 5: I'd never experience, The pain of osteo Arthur writers.
- 53:58Speaker 6: Yox is here. Medicine for ustioar threat is pain. With
- 54:02Speaker 6: one little pill of day, biox can provide powerful twenty
- 54:05Speaker 6: four hour relief. Biox specifically targets only the COX two enzyme.
- 54:09Speaker 6: A key source of our threat is pain. People with
- 54:12Speaker 6: allergic reactions such as asthma to aspirin or other arthreatus
- 54:15Speaker 6: medicines should not take bios. In rare cases, serious stomach
- 54:19Speaker 6: problems such as bleeding can occur without warning. Tell your
- 54:22Speaker 6: doctor if you have liver or kidney problems. For more information,
- 54:25Speaker 6: talk to your doctor about once daily biox for the
- 54:28Speaker 6: relief of ostio war threat is pain.
- 54:30Speaker 5: Perhaps my biggest victory is to be able to plan
- 54:33Speaker 5: my day around my life instead of my pain after.
- 54:36Speaker 6: Your doctor Biox is right for you, bios for everyday victories.
- 54:42Speaker 2: First of all, I take back what I said about
- 54:43Speaker 2: her hair. I think it actually looked really good there.
- 54:46Speaker 2: I don't know, like time and the cycle change and fashion.
- 54:51Speaker 1: I don't know it was the Viox. You don't know.
- 54:53Speaker 1: Maybe vix makes your hair look great.
- 54:55Speaker 2: Everybody. It's a by Biox. It's a brilliant strategy. Like
- 54:58Speaker 2: the people who grew up watching her and knew who
- 55:01Speaker 2: she was and admired her are that age where they
- 55:03Speaker 2: were having lots of the osteoarthritis and joint pains looking
- 55:08Speaker 2: for medication. It's a she's the perfect spokesperson. Yeah, and
- 55:12Speaker 2: she has that innocence so that you believe, you know.
- 55:15Speaker 1: Yeah. And the Dorothy hammel Ads are a huge success.
- 55:18Speaker 1: Millions of Americans saw their former child sweetheart skating and
- 55:22Speaker 1: skiing and living an active, healthy life thanks to this
- 55:24Speaker 1: new miracle drug, and millions of them decided I want
- 55:28Speaker 1: that for myself, And ultimately tens of thousands of them
- 55:32Speaker 1: are going to die as a result. And that's the
- 55:34Speaker 1: story we're going to tell in Part two. Kaba can't wait,
- 55:37Speaker 1: Yay But first off, do you have anything to plug
- 55:39Speaker 1: before we roll out here?
- 55:41Speaker 2: I do plug is my show. That is the plug
- 55:44Speaker 2: that I want to plug is my show. I'm plugging
- 55:47Speaker 2: it now. It's called The House of Pod. It is
- 55:50Speaker 2: a humor adjacent medical podcast. If you like the subjects,
- 55:55Speaker 2: like today's subject, you'll like our show. In fact, one
- 55:58Speaker 2: of our most recent episodes is about sort of similar
- 56:02Speaker 2: a little bit less egregious, but similar pharmaceutical shenanigaree. I
- 56:08Speaker 2: don't know if that's a word about the medication zygris
- 56:11Speaker 2: And and there's all kinds of fun guests like Robert
- 56:15Speaker 2: and prop and all the people you know and love here, Margaret.
- 56:20Speaker 2: So check out my show, The House of Pod. And
- 56:23Speaker 2: if you want, you can follow me at Blue Sky,
- 56:25Speaker 2: which I'm giving a shot now. Seems a little bit
- 56:27Speaker 2: less fascist.
- 56:28Speaker 1: Yeah, definitely less fascist. It's got its own annoyances, but
- 56:32Speaker 1: all of social media has things that annoy me. So
- 56:34Speaker 1: what are you gonna do exactly?
- 56:35Speaker 2: You can follow me there at Cave MD.
- 56:37Speaker 1: You can also follow me there and I write, okay,
- 56:40Speaker 1: where you can follow me on the other place too,
- 56:42Speaker 1: But you know what you could do that I would
- 56:44Speaker 1: appreciate most get off the internet. Feed somebody you know
- 56:49Speaker 1: do something good in the world. Like it online, I
- 56:53Speaker 1: like it. And to listen to podcasts. Keep listening. For
- 56:56Speaker 1: the love of God, keep listening. Do not stop listening
- 56:59Speaker 1: to the podcast under no circumstances.
- 57:01Speaker 2: Stop. Will you ever stop? In fact no, just for
- 57:04Speaker 2: thinking about stopping. You should listen to extra podcasts today.
- 57:08Speaker 1: Yeah, you know what, I'll say it right now. If
- 57:10Speaker 1: you have stomach holcers podcast on the podcast.
- 57:12Speaker 2: Your Way Through It podcast Your Way Through.
- 57:14Speaker 1: It, that's right.
- 57:19Speaker 3: Behind the Bastards is a production of cool Zone Media.
- 57:22Speaker 3: For more from cool Zone Media, visit our website Coolzonemedia
- 57:26Speaker 3: dot com or check us out on the iHeartRadio app,
- 57:29Speaker 3: Apple Podcasts, or wherever you get your podcasts. Behind the
- 57:32Speaker 3: Bastards is now available on YouTube, new episodes every Wednesday
- 57:36Speaker 3: and Friday.
- 57:37Speaker 1: Subscribe to our
- 57:38Speaker 3: Channel YouTube dot com slash at Behind the Bastards